Trials / Completed
CompletedNCT01688843
Safety and Performance Study of the INGEVITY Lead
INGEVITY(TM) Active Fixation and Passive Fixation Pace/ Sense Lead Clinical Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,060 (actual)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to gather data to establish the safety, performance and effectiveness of the INGEVITY pace/ sense leads.
Detailed description
The objective of this study is to gather data to establish the safety, performance and effectiveness of the INGEVITY pace/ sense leads
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | INGEVITY lead |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2015-01-01
- Completion
- 2019-02-01
- First posted
- 2012-09-20
- Last updated
- 2020-03-10
- Results posted
- 2017-11-17
Locations
78 sites across 16 countries: United States, Australia, Austria, Belgium, Canada, Denmark, France, Germany, Hong Kong, Italy, Malaysia, Portugal, Spain, Sweden, Thailand, United Kingdom
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT01688843. Inclusion in this directory is not an endorsement.